Ex vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine

Clinical and Vaccine Immunology

Volumn 17, Issue 9, 2010, Pages 1305-1314

  Salerno Goncalves, Rosângela ^a   Wahid, Rezwanul ^a   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; TYPHOID VACCINE;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; LONGEVITY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SALMONELLA ENTERICA;

ADMINISTRATION, ORAL; ADULT; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMAN EXPERIMENTATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; POLYSACCHARIDES, BACTERIAL; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

EID: 77956408002     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00234-10     Document Type: Article

References (42)

1. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen- specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
2. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, M. Roederer, and R. A. Koup. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
3. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 391:795-799.
4. Coren, L. V., T. Shatzer, and D. E. Ott. 2008. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology 5:64.
5. Crump, J. A., S. P. Luby, and E. D. Mintz. 2004. The global burden of typhoid fever. Bull. World Health Organ. 82:346-353.
6. Di Genova, G., J. Roddick, F. McNicholl, and F. K. Stevenson. 2006. Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood 107:2806-2813.
7. Eisenstein, T. K. 1999. Mucosal Immune defense: the Salmonella typhimurium model, p. 51-108. In Y. Paterson (ed.), Intracellular bacterial vaccine vectors. Wiley-Liss, New York, NY.
8. Ferreccio, C., M. M. Levine, H. Rodriguez, and R. Contreras. 1989. Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J. Infect. Dis. 159:766-769.
9. Guzman, C. A., S. Borsutzky, M. Griot-Wenk, I. C. Metcalfe, J. Pearman, A. Collioud, D. Favre, and G. Dietrich. 2006. Vaccines against typhoid fever. Vaccine 24:3804-3811.
10. Heinzel, A. S., J. E. Grotzke, R. A. Lines, D. A. Lewinsohn, A. L. McNabb, D. N. Streblow, V. M. Braud, H. J. Grieser, J. T. Belisle, and D. M. Lewinsohn. 2002. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J. Exp. Med. 196:1473-1481.
11. Hoare, H. L., L. C. Sullivan, G. Pietra, C. S. Clements, E. J. Lee, L. K. Ely, T. Beddoe, M. Falco, L. Kjer-Nielsen, H. H. Reid, J. McCluskey, L. Moretta, J. Rossjohn, and A. G. Brooks. 2006. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7:256-264.
12. Ivanoff, B., M. M. Levine, and P. H. Lambert. 1994. Vaccination against typhoid fever: present status. Bull. World Health Organ. 72:957-971.
13. Johansson-Lindbom, B., and W. W. Agace. 2007. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev. 215:226-242.
14. Lamoreaux, L., M. Roederer, and R. Koup. 2006. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1:1507-1516.
15. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951-4960.
16. Levine, M. M., C. Ferreccio, P. Abrego, O. S. Martin, E. Ortiz, and S. Cryz. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17:S22-S27.
17. Levine, M. M., C. Ferreccio, R. E. Black, and R. Germanier. 1987. Largescale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1:1049-1052.
18. Levine, M. M., and O. S. Levine. 1997. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Lancet 350:1386-1392.
19. Levine, M. M., and M. B. Sztein. 2004. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 5:460-464.
20. Miller, J. D., R. G. van der Most, R. S. Akondy, J. T. Glidewell, S. Albott, D. Masopust, K. Murali-Krishna, P. L. Mahar, S. Edupuganti, S. Lalor, S. Germon, C. Del Rio, M. J. Mulligan, S. I. Staprans, J. D. Altman, M. B. Feinberg, and R. Ahmed. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722.
21. Motulsky, H., and A. Christopoulos. 2004. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting. Oxford University Press, New York, NY.
22. Pietra, G., C. Romagnani, P. Mazzarino, M. Falco, E. Millo, A. Moretta, L. Moretta, and M. C. Mingari. 2003. HLA-E-restricted recognition of cytomegalovirus- derived peptides by human CD8+ cytolytic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 100:10896-10901.
23. Precopio, M. L., M. R. Betts, J. Parrino, D. A. Price, E. Gostick, D. R. Ambrozak, T. E. Asher, D. C. Douek, A. Harari, G. Pantaleo, R. Bailer, B. S. Graham, M. Roederer, and R. A. Koup. 2007. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204:1405-1416.
24. Pulendran, B., and R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124:849-863.
25. Robinson, H. L., and R. R. Amara. 2005. T cell vaccines for microbial infections. Nat. Med. 11:S25-S32.
26. Rodgers, J. R., and R. G. Cook. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5:459-471.
27. Salerno-Gonçalves, R., M. Fernandez-Vina, D. M. Lewinsohn, and M. B. Sztein. 2004. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173:5852-5862.
28. Salerno-Goncalves, R., M. F. Pasetti, and M. B. Sztein. 2002. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169:2196-2203.
29. Salerno-Gonçalves, R., and M. B. Sztein. 2006. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol. 14:536-542.
30. Salerno-Goncalves, R., and M. B. Sztein. 2009. Priming of Salmonella enterica serovar Typhi-specific CD8(+) T cells by suicide dendritic cell crosspresentation in humans. PLoS One 4:e5879.
31. Salerno-Gonçalves, R., R. Wahid, and M. B. Sztein. 2005. Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires. Infect. Immun. 73:3521-3530.
32. Salerno-Gonçalves, R., T. L. Wyant, M. F. Pasetti, M. Fernandez-Vina, C. O. Tacket, M. M. Levine, and M. B. Sztein. 2003. Concomitant induction of CD4(+) and CD8(+) T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain CVD 908-htrA. J. Immunol. 170:2734-2741.
33. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763.
34. Shawar, S. M., J. M. Vyas, J. R. Rodgers, and R. R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839-880.
35. Sullivan, L. C., C. S. Clements, J. Rossjohn, and A. G. Brooks. 2008. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 72:415-424.
36. Sullivan, L. C., H. L. Hoare, J. McCluskey, J. Rossjohn, and A. G. Brooks. 2006. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27:413-420.
37. Sztein, M. B. 2007. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans. Clin. Infect. Dis. 45(Suppl. 1):S15-S19.
38. Sztein, M. B., M. K. Tanner, Y. Polotsky, J. M. Orenstein, and M. M. Levine. 1995. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 155:3987-3993.
39. Sztein, M. B., S. S. Wasserman, C. O. Tacket, R. Edelman, D. Hone, A. A. Lindberg, and M. M. Levine. 1994. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170:1508-1517.
40. Wahid, R., R. Salerno-Goncalves, C. O. Tacket, M. M. Levine, and M. B. Sztein. 2007. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 25:1416-1425.
41. Wahid, R., R. Salerno-Goncalves, C. O. Tacket, M. M. Levine, and M. B. Sztein. 2008. Generation of specific effector and memory T cells with gutand secondary lymphoid tissue-homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunol. 1:389-398.
42. Wills, M. R., A. J. Carmichael, M. P. Weekes, K. Mynard, G. Okecha, R. Hicks, and J. G. Sissons. 1999. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J. Immunol. 162:7080-7087.